insights_auto
Why is EII up ४.२६%?
Dive Deeperchevron_right
EII:FRA
Eisai Co Ltd
€ २९.६१
arrow_upward
+४.२६%(+१.२१) 1D
नोभेम्बर १३, ११:४४:४८ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EII...
Open
€ २८.९७
High
€ २९.६१
Low
€ २८.४७
Mkt. cap
१५.१२ खरब
Avg. vol.
२३९.००
Volume
१.९९ हजार
52-wk high
€ ३१.०२
52-wk low
€ १९.७०
No. of employees
११ हजार
Open
€ २८.९७
High
€ २९.६१
Low
€ २८.४७
Mkt. cap
१५.१२ खरब
Avg. vol.
२३९.००
Volume
१.९९ हजार
52-wk high
€ ३१.०२
52-wk low
€ १९.७०
No. of employees
११ हजार
News stories
From web sources and news partners
Yahoo Finance
·
१४ घण्टा पहिले
LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease
Seeking Alpha
·
१४ घण्टा पहिले
Eisai Co., Ltd. 2027 Q2 - Results - Earnings Call Presentation (OTCMKTS:ESAIY) 2026-11-12
finance.biggo.com
·
२ दिन पहिले
[Eisai FY2026 Q2 Earnings Call] Eisai Posts 20.4% Rise in Interim Operating Profit to ¥41.4 Billion - Subcutaneous Leqembi Winning Patients at 4x the Pace of IV; Full-Year ¥70 Billion Target "Aiming for Upside"
Investing.com
·
३ दिन पहिले
Eisai Q2 FY2026 slides: 3L products drive 17.5% revenue growth
Profile
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
About Eisai Co Ltd
CEOHaruo Naito | Haruo Naito
Employees१०.५ हजार
Founded१९४१ डिसेम्बर ६
HeadquartersBunkyo City, टोक्यो, जापान
SectorHealth Care
Industry-
Websiteeisai.co.jp